{
    "version": "STOPP/START NL 2020",
    "last_modified": "2025-06-18",
    "criteria": [
        {
            "id": "STOP A1",
            "type": "STOP",
            "category": "ALGEMEEN",
            "description": "Elk medicijn zonder een op bewijs gebaseerde klinische indicatie",
            "argument": "",
            "group_codes": [],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP A2",
            "type": "STOP",
            "category": "ALGEMEEN",
            "description": "Elk medicijn dat langer dan de aanbevolen duur voor de betreffende indicatie wordt voorgeschreven",
            "argument": "",
            "group_codes": [],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },         
        {
            "id": "STOP A3",
            "type": "STOP",
            "category": "ALGEMEEN",
            "description": "Dubbelmedicatie (verschillende medicijnen uit dezelfde geneesmiddelgroep), bijvoorbeeld 2 NSAID's, SSRI's, lisdiuretica, ACE-remmers of orale anticoagulantia",
            "argument": "",
            "group_codes": [],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "active": true,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },  
        {
            "id": "STOP B1",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Verapamil of diltiazem bij hartfalen met een verminderde linkerventrikel ejectiefractie (HFrEF)",
            "argument": "Kan hartfalen verergeren.",
            "group_codes": [],
            "substances": ["verapamil", "diltiazem"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B2",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Bètablokker in combinatie met verapamil of diltiazem",
            "argument": "Risico op hartblok.",
            "group_codes": [],
            "substances": [],
            "combination_x": ["betablokkers_met_diureticum", "betablokkers__oculair", "betablokkers__systemisch"],
            "combination_y": ["verapamil", "diltiazem"],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B3",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Bètablokker bij bradycardie (< 50/min), tweede-graads blok of compleet AV-blok. N.B. Dosis verlagen of stoppen",
            "argument": "Risico op compleet hartblok, asystolie",
            "group_codes": ["betablokkers_met_diureticum", "betablokkers__oculair", "betablokkers__systemisch"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B4",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Lisdiureticum als behandeling van hypertensie",
            "argument": "Niet geregistreerd voor deze indicatie. Veiligere en doeltreffendere alternatieven beschikbaar",
            "group_codes": ["lisdiuretica"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B5",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Amiodaron als antiaritmicum",
            "argument": "Hoog risico op bijwerkingen",
            "group_codes": [],
            "substances": ["amiodaron"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B6",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Lisdiureticum bij enkeloedeem zonder klinisch, biochemisch of radiologisch bewijs van hartfalen, leverfalen, nefrotisch syndroom of nierinsufficiëntie",
            "argument": "Risico op elektrolytstoornissen, dehydratie, hypovolemie, (orthostatische) hypotensie. Indien mogelijk compressietherapie, gevolgd door elastische kousen en bewegen of been in hoogstand",
            "group_codes": ["lisdiuretica"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B7",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Thiazidediureticum bij: - actuele hypokaliëmie (serumconcentratie kalium < 3,0 mmol/l), - hyponatriëmie (serumconcentratie natrium < 130 mmol/l), - hypercalciëmie (gecorrigeerde serumconcentratie niet-eiwitgebonden calcium > 2,65 mmol/l) of voorgeschiedenis van jicht bij gelijktijdig gebruik van thiazidediureticum",
            "argument": "Kan hypokaliëmie, hyponatriëmie, hypercalciëmie of jicht uitlokken",
            "group_codes": ["thiaziden", "betablokkers_met_diureticum", "arb_s_met_diureticum", "ace_remmer_met_diureticum", "dihydropyridinen__overige_combinatiepreparaten", "diuretica__combinatiepreparaten", "ace_remmers__overige_combinatiepreparaten"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B8",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "ACE-remmer, angiotensine II-antagonist en/of aldosteronantagonist (spironolacton, eplerenon) bij patiënten met klinisch relevante hyperkaliëmie (> 5,5 mmol/l)",
            "argument":"Verergering van hyperkaliëmie",
            "group_codes": ["ace_remmer_met_diureticum", "ace_remmers", "ace_remmers_met_calciumantagonist", "ace_remmers__overige_combinatiepreparaten" ,"arb_s_met_calciumantagonist", "arb_s", "arb_s_met_diureticum", "arb_s_met_neprilysineremmer", "diuretica__kaliumsparende"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B9",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Combinatie aldosteronantagonist (spironolacton, eplerenon) met kaliumspaarder (ACE-remmer, angiotensine II-antagonist,amiloride of triamtereen) zonder regelmatige controle van de kaliumconcentratie",
            "argument": "Risico op hyperkaliëmie. Ten minste halfjaarlijkse controle van de serumconcentratie kalium",
            "group_codes": [],
            "substances": [],
            "combination_x": ["diuretica__kaliumsparende"],
            "combination_y": ["ace_remmer_met_diureticum", "ace_remmers", "ace_remmers__overige_combinatiepreparaten", "ace_remmers_met_calciumantagonist", "arb_s", "arb_s_met_calciumantagonist", "arb_s_met_diureticum", "arb_s_met_neprilysineremmer", "diuretica__combinatiepreparaten"],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B10",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Combinatie ACE-remmer met angiotensine II-antagonist",
            "argument": "Risico op nierfalen",
            "group_codes": [],
            "substances": [],
            "combination_x": ["ace_remmer_met_diureticum", "ace_remmers", "ace_remmers__overige_combinatiepreparaten", "ace_remmers_met_calciumantagonist"],
            "combination_y": ["arb_s", "arb_s_met_calciumantagonist", "arb_s_met_diureticum", "arb_s_met_neprilysineremmer"],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B11",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Fosfodiësterase 5-remmer (sildenafil, tadalafil, vardenafil, avanafil) bij ernstig hartfalen, gekenmerkt door hypotensie (systolische bloeddruk < 90 mmHg) of in combinatie met nitraatgebruik",
            "argument": "Risico op cardiovasculaire collaps",
            "group_codes": ["fosfodi_esterase_5_remmers"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B12",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Lipidenverlagende medicatie bij kwetsbaarheid zonder hart- en vaatziekten",
            "argument": "Geen cardiovasculair voordeel",
            "group_codes": ["statinen", "lipidenverlagende_middelen__combinatiepreparaten", "lipidenverlagende_middelen__overige"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B13",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Lipidenverlagende medicatie bij: - kwetsbaarheid met hart-vaatziekten en spierpijn of - gering geschatte levensverwachting (< 1 jaar)",
            "argument": "Weinig tot geen cardiovasculair voordeel",
            "group_codes": ["statinen", "lipidenverlagende_middelen__combinatiepreparaten", "lipidenverlagende_middelen__overige"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP B14",
            "type": "STOP",
            "category": "CARDIOVASCULAIR",
            "description": "Digoxine: - > 0,125 mg/dag bij patiënten 70-85-jaar - > 0,0625 mg/dag bij patiënten > 85 jaar",
            "argument": "Risico op toxicitei",
            "group_codes": [],
            "substances": ["digoxine"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-11"
        },
        {
            "id": "STOP C1",
            "type": "STOP",
            "category": "TROMBOCYTENAGGREGATIEREMMERS/ ANTISTOLLING",
            "description": "Salicylaat als trombocytenaggregatieremmer: - acetylsalicylzuur > 80 mg/dag. - carbasalaatcalcium > 100 mg/dag met uitzondering van oplaaddosis",
            "argument": "Verhoogd risico op bloeding. Niet bewezen effectief",
            "group_codes": ["salicylaten_als_trombocytenaggregatieremmer"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP C2",
            "type": "STOP",
            "category": "TROMBOCYTENAGGREGATIEREMMERS/ ANTISTOLLING",
            "description": "Trombocytenaggregatieremmer (salicylaat, clopidogrel of andere P2Y12-remmer, dipyridamol), cumarine en/of direct werkend oraal anticoagulans (DOAC) bij verhoogd risico op bloedingen (bijvoorbeeld ongecontroleerde hypertensie), versterkte bloedingsneiging ofrecente relevante spontane bloeding",
            "argument": "Verhoogd risico op bloeding",
            "group_codes": ["salicylaten_als_trombocytenaggregatieremmer",  "p2y12_remmers", "trombocytenaggregatieremmers__overige", "vitamine_k_antagonisten", "directwerkende_orale_anticoagulantia"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP C3",
            "type": "STOP",
            "category": "TROMBOCYTENAGGREGATIEREMMERS/ ANTISTOLLING",
            "description": "Combinatie trombocytenaggregatieremmer met cumarine of DOAC bij patiënten met chronisch atriumfibrilleren, uitgezonderd patiënten met recente coronaire stentplaatsing (< 12 maanden)",
            "argument": "Geen extra voordeel bij verhoogde kans op bloedingen",
            "group_codes": [],
            "substances": [],
            "combination_x": ["salicylaten_als_trombocytenaggregatieremmer", "trombocytenaggregatieremmers__overige"],
            "combination_y": ["directwerkende_orale_anticoagulantia", "vitamine_k_antagonisten"],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP C4",
            "type": "STOP",
            "category": "TROMBOCYTENAGGREGATIEREMMERS/ ANTISTOLLING",
            "description": "Combinatie trombocytenaggregatieremmer met cumarine of DOAC bij patiënten met stabiele coronaire, cerebrovasculaire of perifere arteriële symptomen",
            "argument": "Geen bewijs voor extra voordeel van combinatietherapie",
            "group_codes": [],
            "substances": [],
            "combination_x": ["salicylaten_als_trombocytenaggregatieremmer", "trombocytenaggregatieremmers__overige"],
            "combination_y": ["directwerkende_orale_anticoagulantia", "vitamine_k_antagonisten"],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP C5",
            "type": "STOP",
            "category": "TROMBOCYTENAGGREGATIEREMMERS/ ANTISTOLLING",
            "description": "Cumarine of DOAC: - ≥ 3 maanden bij een eerste episode secundaire VTE. - ≥ 3 maanden: a: bij eerste episode idiopatische VTE of recidief VTE én b: verhoogd bloedingsrisico (in overleg met internist)",
            "argument": "Geen bewijs voor aanvullende effectiviteit",
            "group_codes": ["vitamine_k_antagonisten", "directwerkende_orale_anticoagulantia"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP C6",
            "type": "STOP",
            "category": "TROMBOCYTENAGGREGATIEREMMERS/ ANTISTOLLING",
            "description": "Combinatie van antitrombotica > 12 maanden: P2Y12-remmer met salicylaat/cumarine/DOAC",
            "argument": "Verhoogde kans op bloedingen",
            "group_codes": [],
            "substances": [],
            "combination_x": ["p2y12_remmers"],
            "combination_y": ["salicylaten_als_trombocytenaggregatieremmer", "vitamine_k_antagonisten", "directwerkende_orale_anticoagulantia"],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP C7",
            "type": "STOP",
            "category": "TROMBOCYTENAGGREGATIEREMMERS/ ANTISTOLLING",
            "description": "Drievoudige combinatie van antitrombotica > 1-6 maanden: acetylsalicylzuur, clopidogrel met cumarine/DOAC",
            "argument": "Verhoogde kans op bloedingen",
            "group_codes": [],
            "substances": [],
            "combination_x": ["acetylsalicylzuur"],
            "combination_y": ["clopidogrel"],
            "combination_z": ["vitamine_k_antagonisten", "directwerkende_orale_anticoagulantia"],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D1",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Tricyclisch antidepressivum bij recent hartinfarct (< 6 maanden), terughoudendheid bij dementie, urineretentie, lever- en nierfunctiestoornis, glaucoom, epilepsie, ernstig hartfalen in verband met anticholinerg effect. N.B. Anticholinerg effect is het sterkst bij amitriptyline en het minst bij nortriptyline",
            "argument": "Risico op verergering van deze aandoeningen",
            "group_codes": ["tricyclische_antidepressiva"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D2",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Tricyclisch antidepressivum als eerste keus bij depressie",
            "argument": "Hoog risico op bijwerkingen",
            "group_codes": ["tricyclische_antidepressiva"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D3",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Antipsychoticum met matig anticholinerg effect (chloorpromazine, flupentixol, flufenazine, zuclopentixol) bij prostatisme of voorgeschiedenis van urineretentie",
            "argument": "Hoog risico op urineretentie",
            "group_codes": [],
            "substances": ["chloorpromazine", "flupentixol", "flufenazine", "zuclopentixol"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D4",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "SSRI bij niet-iatrogene hyponatriëmie < 2 maanden (serumconcentratie natrium < 130 mmol/l)",
            "argument": "Risico op verergering of recidief hyponatriëmie",
            "group_codes": ["serotonineheropnameremmers__selectief"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D5",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Benzodiazepine ≥ 4 weken. N.B. geleidelijk afbouwen bij gebruik > 4 weken vanwege risico op ontwenningssymptomen en dosisescalatie",
            "argument": "Geen indicatie voor langere behandeling. Risico op verlengde sedatie, verwardheid, slechtere balans, vallen, verkeersongevallen",
            "group_codes": ["benzodiazepine_agonisten"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D6",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Antipsychoticum (met uitzondering van clozapine en quetiapine) bij patiënten met parkinsonisme",
            "argument": "Risico op ernstige extrapiramidale bijwerkingen",
            "group_codes": ["antipsychotica__klassieke"],
            "substances": ["amisulpiride", "aripiprazol", "brexpiprazol", "cariprazine", "lurasidon", "olanzapine", "paliperidon", "risperidon", "sertindol", "sulpiride"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D7",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Anticholinergicum, zoals biperideen of trihexyfenidyl, bij extrapiramidale bijwerkingen van antipsychotica",
            "argument": "Verhoogd risico op anticholinerge toxiciteit",
            "group_codes": [],
            "substances": [],
            "combination_x": ["biperideen", "trihexyfenidyl"],
            "combination_y": ["antipsychotica__klassieke", "antipsychotica__atypische"],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D8",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Middelen met anticholinerge bijwerkingen bij patiënten met delier of dementie",
            "argument": "Verhoogd risico op verergering van cognitieve stoornissen",
            "group_codes": [],
            "substances": ["amitriptyline", "nortriptyline", "imipramine", "clomipramine", "dosulepine", "trimipramine", "paroxetine", "fluoxetine", "sertraline", "citalopram", "escitalopram", "venlafaxine", "duloxetine", "clozapine", "olanzapine", "quetiapine", "risperidon", "aripiprazol", "paliperidon", "chloorpromazine", "thioridazine", "levomepromazine", "perfenazine", "haloperidol", "zuclopentixol", "flupentixol", "hydroxyzine", "alprazolam", "biperideen", "trihexyfenidyl", "orfenadrine", "procyclidine", "carbamazepine", "oxcarbazepine","promethazine", "diphenhydramine", "scopolamine"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D9",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Antipsychoticum bij patiënten met probleemgedrag bij dementie, tenzij symptomen zeer ernstig of in de acute fase zijn en niet-medicamenteuze maatregelen geen effect hebben",
            "argument": "Beperkte effectiviteit, verhoogd risico",
            "group_codes": ["antipsychotica__atypische", "antipsychotica__klassieke"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D10",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Antipsychoticum of antidepressivum als slaapmiddel",
            "argument": "Risico op verwardheid, hypotensie, extrapiramidale bijwerkingen, vallen",
            "group_codes": ["antipsychotica__atypische", "antipsychotica__klassieke", "tricyclische_antidepressiva", "serotonineheropnameremmers__selectief", "lithiumzouten", "tetracyclische_antidepressiva", "antidepressiva__overige", "mao_a_remmers", "mao_remmers__niet_selectief", "serotonineheropnameremmers__niet_selectief", "melatonine_agonisten"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D11",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Acetylcholinesteraseremmer bij bradycardie (< 60 slagen/min), hartblok of recidiverende, onverklaarde syncope",
            "argument": "Risico op manifeste hartgeleidingsstoornissen, syncope en verwonding",
            "group_codes": ["cholinesteraseremmers__centraal_werkend", "cholinesteraseremmers__kwaternaire_ammoniumbasen"],
            "substances": ["fysostigmine"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D12",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Levodopa of dopamineagonist voor benigne essentiële tremor",
            "argument": "Niet bewezen effectief",
            "group_codes": ["dopamine_agonisten__overige", "levodopa_met_decarboxylaseremmers"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP D13",
            "type": "STOP",
            "category": "CENTRAAL ZENUWSTELSEL EN PSYCHOFARMACA",
            "description": "Antihistaminicum met centrale antihistaminerge (sederende) werking",
            "argument": "Voldoende niet-sederende antihistaminica beschikbaar als alternatief",
            "group_codes": [],
            "substances": ["alimemazine", "clemastine", "hydroxyzine", "meclozine", "meclozine/pyridoxine", "promethazine", "tripelennamine"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-17"
        },
        {
            "id": "STOP E1",
            "type": "STOP",
            "category": "POTENTIEEL ONGESCHIKTE MEDICATIE BIJ VERMINDERDE NIERFUNCTIE",
            "description": "Dabigatran bij eGFR < 30 ml/min/1,73 m2",
            "argument": "Verhoogd risico op bloeding",
            "group_codes": [],
            "substances": ["dabigatran"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP E2",
            "type": "STOP",
            "category": "POTENTIEEL ONGESCHIKTE MEDICATIE BIJ VERMINDERDE NIERFUNCTIE",
            "description": "NSAID bij eGFR < 30 ml/min/1,73 m2",
            "argument": "Risico op acute nierinsufficiëntie",
            "group_codes": ["nsaid_s__systemisch", "nsaid_s__cutaan", "nsaid_s_met_maagbeschermer", "nsaid_s__oculair"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP E3",
            "type": "STOP",
            "category": "POTENTIEEL ONGESCHIKTE MEDICATIE BIJ VERMINDERDE NIERFUNCTIE",
            "description": "Sulfonylureumderivaten, uitgezonderd gliclazide en tolbutamide, bij achteruitgang van de nierfunctie (eGFR < 50 ml/min/1,73 m2) en/of hypoglykemie",
            "argument": "Gliclazide is een veiliger alternatief",
            "group_codes": [],
            "substances": ["glimepiride"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP E4",
            "type": "STOP",
            "category": "POTENTIEEL ONGESCHIKTE MEDICATIE BIJ VERMINDERDE NIERFUNCTIE",
            "description": "Alendroninezuur, etidroninezuur, ibandroninezuur of risedroninezuur bij eGFR < 30 ml/min/1,73 m2",
            "argument": "Risico op toxiciteit",
            "group_codes": [],
            "substances": ["alendroninezuur", "etidroninezuur", "ibandroninezuur", "risedroninezuur"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP F1",
            "type": "STOP",
            "category": "GASTRO-INTESTINAAL",
            "description": "Metoclopramide bij parkinsonisme",
            "argument": "Verhoogd risico op verergering van parkinsonisme door centrale dopamineblokkade. Domperidon is een alternatief",
            "group_codes": [],
            "substances": ["metoclopramide", "acetylsalicylzuur/metoclopramide"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP F2",
            "type": "STOP",
            "category": "GASTRO-INTESTINAAL",
            "description": "Protonpompremmer in maximale therapeutische dosis > 8 weken bij peptische ulcera of oesofagitis, uitzonderd barrettoesofagus of syndroom van Zollinger-Ellison",
            "argument": "",
            "group_codes": ["protonpompremmers"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP F3",
            "type": "STOP",
            "category": "GASTRO-INTESTINAAL",
            "description": "Geneesmiddelen die obstipatie kunnen veroorzaken of verergeren (bijvoorbeeld anticholinerge medicatie, opioïden, verapamil,aluminiumhoudende antacida) bij patiënten met chronische obstipatie",
            "argument": "Risico op verergering van obstipatie",
            "group_codes": ["opioiden"],
            "substances": ["oxybutynine", "tolterodine", "fesoterodine", "solifenacine", "darifenacine", "trospium", "biperideen", "trihexyfenidyl","orfenadrine", "procyclidine", "butylscopolamine", "atropine", "hyoscine", "dicycloverine", "methylscopolamine", "propantheline", "verapamil", "algeldraat/magnesiumhydroxide", "algeldraat/magnesiumhydroxide/dimeticon"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP F4",
            "type": "STOP",
            "category": "GASTRO-INTESTINAAL",
            "description": "IJzerpreparaten met gereguleerde afgifte of als bruistablet (ferrosulfaat mga/ferrogluconaat)",
            "argument": "Interacties en kans op darmobstructie. Mindere opname dan tabletten zonder gereguleerde afgifte. Geen bewijs voor minder bijwerkingen of betere opname",
            "group_codes": [],
            "substances": ["ferrosulfaat", "ferrogluconaat"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP F5",
            "type": "STOP",
            "category": "GASTRO-INTESTINAAL",
            "description": "Orale ijzersuppletie > 2 x per week 200 mg ferrofumaraat (of andere equivalente dosering elementair ijzer",
            "argument": "Geen bewijs voor meer opname van ijzer boven deze dosis, wel meer bijwerkingen",
            "group_codes": ["ijzerpreparaten__oraal"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP G1",
            "type": "STOP",
            "category": "RESPIRATOIR",
            "description": "Systemisch glucocorticosteroïd in plaats van inhalatiecorticosteroïd als onderhoudsbehandeling bij matige tot ernstige COPD of astma.",
            "argument": "Onnodige blootstelling aan lange termijn bijwerkingen van systemische glucocorticosteroïden",
            "group_codes": ["corticosteroiden__systemisch"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP H1",
            "type": "STOP",
            "category": "BEWEGINGSAPPARAAT",
            "description": "NSAID bij: - matige tot ernstige hypertensie. - hartfalen",
            "argument": "Kan verergering van hypertensie en hartfalen geven",
            "group_codes": ["nsaid_s__cutaan", "nsaid_s__oculair", "nsaid_s__systemisch", "nsaid_s_met_maagbeschermer"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP H2",
            "type": "STOP",
            "category": "BEWEGINGSAPPARAAT",
            "description": "Langdurig NSAID (> 3 maanden) voor pijnverlichting bij artrose zonder dat paracetamol in adequate dosering geprobeerd is",
            "argument": "Eenvoudige pijnstillers zijn veiliger en meestal even effectief",
            "group_codes": ["nsaid_s__cutaan", "nsaid_s__oculair", "nsaid_s__systemisch", "nsaid_s_met_maagbeschermer"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP H3",
            "type": "STOP",
            "category": "BEWEGINGSAPPARAAT",
            "description": "Langdurig glucocorticosteroïd (> 3 maanden) als monotherapie bij reumatoïde artritis",
            "argument": "Verhoogd risico op systemische bijwerkingen van glucocorticosteroïden",
            "group_codes": ["corticosteroiden__systemisch"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP H4",
            "type": "STOP",
            "category": "BEWEGINGSAPPARAAT",
            "description": "Glucocorticosteroïd bij artrose, uitgezonderd periodieke intra-articulaire injecties voor mono-articulaire pijn",
            "argument": "Risico op systemische bijwerkingen van glucocorticosteroïden",
            "group_codes": ["corticosteroiden__systemisch"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP H5",
            "type": "STOP",
            "category": "BEWEGINGSAPPARAAT",
            "description": "Langdurig NSAID of colchicine bij jicht zonder contra-indicatie voor xanthineoxidaseremmers (allopurinol)",
            "argument": "Xanthineoxidaseremmers zijn profylactische geneesmiddelen van eerste keus bij jicht",
            "group_codes": ["nsaid_s__cutaan", "nsaid_s__oculair", "nsaid_s__systemisch", "nsaid_s_met_maagbeschermer"],
            "substances": ["colchicine"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP H6",
            "type": "STOP",
            "category": "BEWEGINGSAPPARAAT",
            "description": "Combinatie NSAID met cumarine, DOAC of trombocytenaggregatieremmer",
            "argument": "Verhoogd risico op ernstige maagbloeding",
            "group_codes": [],
            "substances": [],
            "combination_x": ["nsaid_s__cutaan", "nsaid_s__oculair", "nsaid_s__systemisch", "nsaid_s_met_maagbeschermer"],
            "combination_y": ["directwerkende_orale_anticoagulantia", "trombocytenaggregatieremmers__overige", "salicylaten_als_trombocytenaggregatieremmer", "vitamine_k_antagonisten"],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP H7",
            "type": "STOP",
            "category": "BEWEGINGSAPPARAAT",
            "description": "NSAID in langdurige of hoge dosering bij (ischemische) hart- en vaatziekten. N.B. Naproxen heeft het laagste cardiovasculaire risico, diclofenac het hoogste (vergelijkbaar met COX-2-selectieve pijnstillers)",
            "argument": "Verhoogd risico op hartinfarct en beroerte",
            "group_codes": ["nsaid_s__cutaan", "nsaid_s__oculair", "nsaid_s__systemisch", "nsaid_s_met_maagbeschermer"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP H8",
            "type": "STOP",
            "category": "BEWEGINGSAPPARAAT",
            "description": "Oraal bisfosfonaat: - bij aandoeningen van het bovenste maag-darmkanaal (dysfagie, oesofagitis, gastritis, duodenitis, maagulcus of bovenste gastro-intestinale bloeding), actueel of in de voorgeschiedenis. - bij bedlegerigheid",
            "argument": "Verhoogd risico op recidief of verergering van aandoening",
            "group_codes": ["bisfosfonaten", "bisfosfonaten__combinatiepreparaten"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP I1",
            "type": "STOP",
            "category": "UROGENITAAL",
            "description": "Selectieve alfa-1-blokker bij incontinentie of bij chronische toepassing van urinecatheter",
            "argument": "Niet bewezen effectief",
            "group_codes": [],
            "substances": ["alfuzosine", "doxazosine", "silodosine", "tamsulosine", "terazosine", "urapidil"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP I2",
            "type": "STOP",
            "category": "UROGENITAAL",
            "description": "Selectieve alfa-1-blokker bij symptomatische orthostase of mictie-syncope",
            "argument": "Risico op verergering symptomen",
            "group_codes": [],
            "substances": ["alfuzosine", "doxazosine", "silodosine", "tamsulosine", "terazosine", "urapidil"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP I3",
            "type": "STOP",
            "category": "UROGENITAAL",
            "description": "Selectieve alfa-1-blokker > 6 maanden bij mictieklachten bij mannen",
            "argument": "Beperkt effect van alfablokkers",
            "group_codes": [],
            "substances": ["alfuzosine", "doxazosine", "silodosine", "tamsulosine", "terazosine", "urapidil"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP I4",
            "type": "STOP",
            "category": "UROGENITAAL",
            "description": "Urologisch spasmolyticum: - > 6-12 maanden. - bij urineretentie (stop direct)",
            "argument": "Beperkt effect",
            "group_codes": ["urologische_spasmolytica"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP J1",
            "type": "STOP",
            "category": "ENDOCRIEN",
            "description": "Sulfonylureumderivaten met langere werkingsduur en actieve metabolieten (glibenclamide, glimepiride)",
            "argument": "Verhoogd risico op (ernstige, langdurige) hypoglykemie. Veiligere alternatieven beschikbaar",
            "group_codes": [],
            "substances": ["metformine/glibenclamide", "glimepiride"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP J2",
            "type": "STOP",
            "category": "ENDOCRIEN",
            "description": "Pioglitazon bij gedocumenteerd of verhoogd risico op hartfalen, blaaskanker en botbreuken",
            "argument": "Verhoogd risico op ontstaan of verergering van deze klachten",
            "group_codes": [],
            "substances": ["pioglitazon", "pioglitazon/metformine"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP J3",
            "type": "STOP",
            "category": "ENDOCRIEN",
            "description": "Bètablokker bij diabetes mellitus met frequente hypoglykemieën",
            "argument": "Kan hypoglykemie maskeren",
            "group_codes": ["betablokkers__systemisch", "betablokkers_met_diureticum", "betablokkers__oculair"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
                {
            "id": "STOP J4",
            "type": "STOP",
            "category": "ENDOCRIEN",
            "description": "Oestrogeen bij borstkanker of veneuze trombo-embolie in de voorgeschiedenis",
            "argument": "Verhoogd risico op recidief",
            "group_codes": ["oestrogenen"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP J5",
            "type": "STOP",
            "category": "ENDOCRIEN",
            "description": "Oraal oestrogeen zonder progestageen bij intacte uterus",
            "argument": "Verhoogd risico op endometriumcarcinoom",
            "group_codes": ["oestrogenen"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP J6",
            "type": "STOP",
            "category": "ENDOCRIEN",
            "description": "Androgeen zonder primair of secundair hypogonadisme",
            "argument": "Mogelijk versnelde progressie van subklinische prostaatkanker en benigne prostaathyperplasie",
            "group_codes": ["androgenen"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP K1",
            "type": "STOP",
            "category": "VERHOOGD VALRISICO",
            "description": "Benzodiazepineagonist (inclusief zolpidem en zopiclon) bij voorgeschiedenis van vallen of valneiging",
            "argument": "Verhoogd risico op sedatie, ataxie, bewustzijnsvermindering en verslechtering balans",
            "group_codes": ["benzodiazepine_agonisten"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP K2",
            "type": "STOP",
            "category": "VERHOOGD VALRISICO",
            "description": "Antipsychoticum of antidepressivum bij voorgeschiedenis van vallen of valneiging",
            "argument": "Risico op parkinsonisme, duizeligheid en orthostatische hypotensie",
            "group_codes": ["antipsychotica__klassieke", "antipsychotica__atypische", "antidepressiva__overige", "serotonineheropnameremmers__selectief", "serotonineheropnameremmers__niet_selectief", "tricyclische_antidepressiva", "tetracyclische_antidepressiva", "mao_a_remmers", "mao_remmers__niet_selectief", "lithiumzouten"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP K3",
            "type": "STOP",
            "category": "VERHOOGD VALRISICO",
            "description": "Vasodilatator (alfa-1-blokker, langwerkend nitraat, calciumantagonist, ACE-remmer, angiotensine II-antagonist) bij orthostatische hypotensie",
            "argument": "Verhoogd risico op syncope en vallen",
            "group_codes": ["dihydropyridinen", "calciumantagonisten__overige", "dihydropyridinen__overige_combinatiepreparaten", "ace_remmer_met_diureticum", "ace_remmers", "ace_remmers__overige_combinatiepreparaten", "ace_remmers_met_calciumantagonist", "arb_s", "arb_s_met_calciumantagonist", "arb_s_met_diureticum", "arb_s_met_neprilysineremmer", "nitraten"],
            "substances": ["alfuzosine", "doxazosine", "silodosine", "tamsulosine", "terazosine", "urapidil"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP K4",
            "type": "STOP",
            "category": "VERHOOGD VALRISICO",
            "description": "Antihypertensivum bij diastolische bloeddruk <70 mmHg (afbouwen of gefaseerd stoppen)",
            "argument": "Verhoogd risico op orthostatische hypotensie en syncope",
            "group_codes": ["betablokkers__systemisch", "betablokkers_met_diureticum", "ace_remmer_met_diureticum", "ace_remmers", "ace_remmers__overige_combinatiepreparaten", "ace_remmers_met_calciumantagonist", "dihydropyridinen", "dihydropyridinen__overige_combinatiepreparaten", "calciumantagonisten__overige", "arb_s", "arb_s_met_calciumantagonist", "arb_s_met_diureticum", "arb_s_met_neprilysineremmer", "thiaziden"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP K5",
            "type": "STOP",
            "category": "VERHOOGD VALRISICO",
            "description": "Opioïd bij voorgeschiedenis van vallen of valneiging",
            "argument": "Verhoogd risico op sedatie, sufheid en slaperigheid",
            "group_codes": ["opioiden"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP L1",
            "type": "STOP",
            "category": "PIJN",
            "description": "Sterkwerkend oraal of transdermaal opioïd (bijvoorbeeld morfine, oxycodon, fentanyl, buprenorfine) bij lichte of matig ernstige niet-maligne (chronische) pijn",
            "argument": "Risico op bijwerkingen en afhankelijkheid",
            "group_codes": ["opioiden"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP L2",
            "type": "STOP",
            "category": "PIJN",
            "description": "Codeïne en tramadol bij lichte of matige (chronische) pijn",
            "argument": "Verhoogd risico op bijwerkingen",
            "group_codes": [],
            "substances": ["tramadol", "paracetamol/tramadol", "codeïne", "paracetamol/codeïne"],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        },
        {
            "id": "STOP L3",
            "type": "STOP",
            "category": "PIJN",
            "description": "Langdurig gebruik van kortwerkend opioïd",
            "argument": "Kortwerkende opioïden hebben alleen een plaats in de behandeling van maligne pijn bij doorbraakpijn",
            "group_codes": ["opioiden"],
            "substances": [],
            "combination_x": [],
            "combination_y": [],
            "requires_age": true,
            "age_min": 70,
            "requires_egfr": false,
            "egfr_operator": null,
            "egfr_value": null,
            "source_version": "STOPP/START NL 2020",
            "last_modified": "2025-06-18"
        }
    ]
    }